Related Experiment Video
Updated: Jul 6, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Hepatocyte growth factor gene therapy for hypertension
Kazuo Komamura1, Jun-Ichi Miyazaki, Enyu Imai
1Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center, Suita, Japan.
Hepatocyte growth factor (HGF) gene therapy using intramuscular electroporation offers a promising, low-toxicity approach for treating hypertension and promoting tissue regeneration. This method enhances cardiovascular and renal health by leveraging HGF
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Gene Therapy
Background:
- Hepatocyte growth factor (HGF) exhibits potent regenerative, anti-apoptotic, anti-fibrotic, and vasodilating properties.
- HGF plays a crucial role in cardiovascular and renal health, with implications for hypertension, arteriosclerosis, and heart failure.
- HGF has demonstrated efficacy in suppressing hypertension and enhancing renal regeneration.
Purpose of the Study:
- To present intramuscular electroporation as a novel and efficient gene delivery method for HGF.
- To explore the therapeutic potential of HGF gene therapy for managing hypertension.
- To highlight the advantages of gene therapy over protein/peptide administration.
Main Methods:
- Utilizing intramuscular electroporation for targeted delivery of the HGF therapeutic gene.
- Comparing the efficacy and safety of gene therapy with systemic administration of purified HGF proteins or peptides.
- Focusing on the application of HGF gene therapy in the context of hypertension treatment.
Main Results:
- Intramuscular electroporation is established as a simple, economical, and low-toxicity gene delivery technique.
- HGF gene therapy demonstrates potential for hypertension management and renal regeneration.
- The method offers a viable alternative to traditional HGF protein administration.
Conclusions:
- Intramuscular electroporation of the HGF gene is a promising therapeutic strategy for hypertension.
- This gene therapy approach supports tissue regeneration and cardiovascular health.
- The technique provides a safe and effective method for delivering therapeutic genes.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Gene Therapy
Hypertension II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Healing I: Introduction

